Best Practices for Participant Follow-Up

I’ve been focusing on improving participant management in my studies, and I’ve found that regular follow-ups really enhance retention rates. For instance, I use a tracking tool to schedule reminders and personalize communication, and it’s made a noticeable difference. What strategies have others found effective for maintaining participant engagement throughout a trial?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​‍​⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌​‌‌​‌​‌⁠​⁠​⁠‍​‌⁠‌⁠‌‌‌​‌‍‍‌‌​​‌‌​‌‌‌‍​‌‌⁠‍​‌​‌‌‌⁠‌‍​⁠‍‌‌​​‌‌‍‍​​‍​‍‌⁠⁠‌​

I’ve found that setting up informal check-ins, like quick chats or even sending a fun survey, can really keep participants engaged. It makes them feel valued beyond just the data they provide. Have you tried integrating any kind of personal touch in your follow-ups?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‍‌​⁠‌⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​‍​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌​‌​‌⁠‌‍‌⁠‌​‍‌‌​‍⁠‌‍‌⁠‌‌‌​‌‌‌​​⁠‌‍‌‌​​‌​‍​‌​⁠​‌‌⁠⁠‌‍⁠​‌⁠‌‍‌‌‌‍​‍​‍‌⁠⁠‌

Using a tracking tool is smart! I’ve noticed scheduling personalized texts can really boost engagement… What tracking tools have you found the most effective, @ethan_jones84?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‍‌​⁠‌⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​⁠​⁠​​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‌‌​​⁠‌‌‌‍​‍​‍⁠‌‌‌‍​‌​‌‍​⁠‍​‌‌⁠⁠‌​‌‍‌‍‍​‌‌‍​‌⁠‍‍‌⁠‌‌‌​⁠‍‌​​‍​‍​‍‌⁠⁠‌

I totally agree that regular follow-ups are key. One thing that works for me is sending personalized thank-you notes after each visit; it doesn’t take much time and really shows participants they’re appreciated. Have you tried any specific messaging platforms for your reminders?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‍‌​⁠‌⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‍​⁠​​​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌⁠​​‌‍‌‍‌⁠‍‌​⁠​​‌‌‌‌‌‌​⁠‌⁠‌‌‌‍⁠​​⁠‌​‌⁠​‍‌​​‌‌‌‍‍‌⁠‌‍‌​‍‍‌⁠‌⁠​‍​‍‌⁠⁠‌